相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of Statin Medications and Risk of Esophageal Adenocarcinoma in Persons with Barrett's Esophagus
Elizabeth D. Kantor et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Aspirin Protects Against Barrett's Esophagus in a Multivariate Logistic Regression Analysis
Zehra B. Omer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma
Ian L. P. Beales et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis
Tusar K. Desai et al.
GUT (2012)
The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett's oesophagus
A. P. Thrift et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma
Lei Sun et al.
DISEASES OF THE ESOPHAGUS (2011)
Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus
Florine Kastelein et al.
GASTROENTEROLOGY (2011)
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Stuart J. Spechler et al.
GASTROENTEROLOGY (2011)
Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
GASTROENTEROLOGY (2010)
Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
C. C. Abnet et al.
BRITISH JOURNAL OF CANCER (2009)
Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort
Piers A. Gatenby et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2009)
Sulindac prevents esophageal adenocarcinomas induced by gastroduodenal reflux in rats
Sung Wook Kim et al.
YONSEI MEDICAL JOURNAL (2007)
Secondary chemoprevention of Barrett's esophagus with celecoxib: Results of a randomized trial
Elisabeth I. Heath et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus
Pieter J. F. de Jonge et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence
Lesley A. Anderson et al.
CANCER RESEARCH (2006)
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barretts oesophagus: a prospective study
TL Vaughan et al.
LANCET ONCOLOGY (2005)
Prevalence of Barrett's esophagus in the general population:: An endoscopic study
J Ronkainen et al.
GASTROENTEROLOGY (2005)
Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma
Kamal E. Bani-Hani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Are screening and surveillance for Barrett's oesophagus really worthwhile?
P Sharma et al.
GUT (2005)
A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats
K Oyama et al.
CARCINOGENESIS (2005)
Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma
P Tsibouris et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas
AP Polednak
INTERNATIONAL JOURNAL OF CANCER (2003)
Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
DA Corley et al.
GASTROENTEROLOGY (2003)
Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus
BS Kaur et al.
GASTROENTEROLOGY (2002)
Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995
AP Vizcaino et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus
NS Buttar et al.
GASTROENTEROLOGY (2002)
Cyclooxygenase-2 expression in Barrett's esophagus
HM Kandil et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
VN Shirvani et al.
GASTROENTEROLOGY (2000)
分享论文
